Tech Company Financing Transactions

Tigercat Pharma Funding Round

On 9/30/2013, Tigercat Pharma announced funding from Remeditex Ventures.

Transaction Overview

Company Name
Announced On
9/30/2013
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Oyster Point Blvd. 202
South San Francisco, CA 94080
USA
Website
Email Address
Not Recorded
Overview
Tigercat Pharma, Inc. offers drug development services. The company hold the ownership of the VPD-737 development program to treat chronic pruritus.The company was founded in 2011.
Profile
Tigercat Pharma LinkedIn Company Profile
Social Media
Tigercat Pharma Company Twitter Account
Company News
Tigercat Pharma News
Facebook
Tigercat Pharma on Facebook
YouTube
Tigercat Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
James Larrick
  James Larrick LinkedIn Profile  James Larrick Twitter Account  James Larrick News  James Larrick on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2013: Cidara Therapeutics venture capital transaction
Next: 9/30/2013: ActivAided Orthotics venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary